- Home
- BNTX vs VRSN Comparison
BNTX vs VRSN Comparison
Compare BNTX & VRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNTX | VRSN |
|---|---|---|
| Founded | 2008 | 1995 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.7B | 25.9B |
| IPO Year | 2019 | 1997 |
Fundamental Metrics
Financial Performance| Metric | BNTX | VRSN |
|---|---|---|
| Price | $96.67 | $297.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 3 |
| Target Price | $133.46 | ★ $317.67 |
| AVG Volume (30 Days) | ★ 1.6M | 584.8K |
| Earning Date | 05-05-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 1.19% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 6.24 |
| Revenue | N/A | ★ $1,656,600,000.00 |
| Revenue This Year | N/A | $6.78 |
| Revenue Next Year | $3.37 | $5.37 |
| P/E Ratio | ★ N/A | $46.91 |
| Revenue Growth | N/A | ★ 6.37 |
| 52 Week Low | $79.81 | $209.34 |
| 52 Week High | $124.00 | $312.48 |
Technical Indicators
Market Signals| Indicator | BNTX | VRSN |
|---|---|---|
| Relative Strength Index (RSI) | 49.89 | 60.92 |
| Support Level | $88.36 | $281.99 |
| Resistance Level | $112.78 | $301.68 |
| Average True Range (ATR) | 2.81 | 6.56 |
| MACD | -1.37 | 0.30 |
| Stochastic Oscillator | 21.24 | 92.35 |
Price Performance
Historical ComparisonAbout BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
About VRSN VeriSign Inc.
Verisign is an operator of critical infrastructure within the domain name system, or DNS. As the registry for some of the world's most popular TLDs, .com and .net, Verisign directs DNS resolvers to the appropriate registry where IP addresses are stored. Verisign's control over its TLDs is regulated by ICANN and the NTIA and are subject to contract renewal every six years. The company generates revenue through annual subscriptions allowing customers to use .com and .net as their TLD of choice for their respective websites.